Biblio
Mixed donor chimerism following stem cell transplantation for sickle cell disease. Curr Opin Hematol. 2023.
. Mediport use as an acceptable standard for CAR T cell infusion. Front Immunol. 2023;14:1239132.
Granulocyte Colony-Stimulating Factor is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease. Transplant Cell Ther. 2021.
Gene therapy in sickle cell disease: Possible utility and impact. Cleve Clin J Med. 2020;87(1):28-29.
. CAR-T cell manufacture: snatching victory when defeat is looming. Transfusion. 2018;58(6):1335-1337.
.